Initial experience of a novel ureteral silicon-covered metallic mesh stent in malignant ureteric obstruction: a single-center retrospective study
2024

Initial Experience with a New Ureteral Stent for Malignant Obstruction

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): Lee Chung Un, Choo Seol Ho, Chung Jae Hoon, Han Deok Hyun

Primary Institution: Samsung Medical Center

Hypothesis

This study aimed to investigate initial experiences and outcomes of a retrograde inserted new silicone-covered metallic ureteric stent (Urexel™) for malignant ureteric obstruction.

Conclusion

The Urexel™ stent provided acceptable success and complication rates in patients with malignant ureteric obstructions.

Supporting Evidence

  • The 6-month success rate was 83.3%, and the 1-year success rate was 70%.
  • Stent migration was observed in 23.1% of cases.
  • Common complications included persistent pain and acute pyelonephritis.

Takeaway

Doctors tested a new type of stent to help people with blocked ureters due to cancer, and it worked pretty well.

Methodology

The study reviewed medical records of 12 patients who underwent Urexel™ stent placement for malignant ureteric obstruction.

Limitations

The study was retrospective with a small sample size and insufficient follow-up period.

Participant Demographics

The median age of patients was 61.5 years, with 3 males and 9 females.

Digital Object Identifier (DOI)

10.1186/s12894-024-01653-y

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication